BioNTech Financials

BioNTech Stock Summary

BioNTech competes with Viridian Therapeutics, Nationwide Building, Pinnacle West, and Digital Realty. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany. BIONTECH operates under Biotechnology classification in Japan and is traded on IOB. It employs 2500 people.

BioNTech Key Financial Ratios

There are many critical financial ratios that BioNTech's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BioNTech SE reports annually and quarterly.

BioNTech Key Balance Sheet Accounts

BioNTech Key Income Statement Accounts

BioNTech Key Cash Accounts

BioNTech Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BioNTech's current stock value. Our valuation model uses many indicators to compare BioNTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioNTech competition to find correlations between indicators driving BioNTech's intrinsic value. More Info.BioNTech SE is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.71  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for BioNTech SE is roughly  1.41 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioNTech's earnings, one of the primary drivers of an investment's value.

BioNTech SE Systematic Risk

BioNTech SE Other Current Liab Over Time

Along with financial statement analysis, the daily predictive indicators of BioNTech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioNTech SE. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioNTech SE based on widely used predictive technical indicators. In general, we focus on analyzing BioNTech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioNTech's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.